In this Healthed lecture, Dr Adam Nelson explains that weight loss should now be considered a therapeutic target in the same way we treat cholesterol and blood pressure when implementing secondary prevention after a heart attack for instance. Dr Nelson will also present evidence for the effectiveness of GLP-1 agonists in this space and how agents such as semaglutide can and should be included in clinical care according to international cardiology guidelines and even our own TGA recommendations.

In this Healthed lecture, Dr Adam Nelson explains that weight loss should now be considered a therapeutic target in the same way we treat cholesterol and blood pressure when implementing secondary prevention after a heart attack for instance. Dr Nelson will also present evidence for the effectiveness of GLP-1 agonists in this space and how agents such as semaglutide can and should be included in clinical care according to international cardiology guidelines and even our own TGA recommendations.

Audio versions of Healthed Webcasts, designed for the busy healthcare professional.

Audio versions of Healthed Webcasts, designed for the busy healthcare professional.

Lectures

Healthed's medical education channel features the latest high quality clinical interviews and lectures from leading experts in their field, offering health professionals a convenient new way to boost their knowledge.

Healthed Australia

Cardiovascular benefits of GLP1s – New evidence

H5N1 is a highly pathogenic avian flu affecting birds globally, with a higher mortality rate than COVID-19 but limited human-to-human spread
Australia is the only continent without H5N1 cases, with strong pandemic preparedness, including antivirals and vaccine stockpiles
At-risk groups include poultry workers and dairy farmers; exposed individuals should be tested, treated with antivirals, and reported to authorities
Symptoms include respiratory and early GI issues; conjunctivitis has been common in U.S. dairy workers
Australia’s new CDC has improved outbreak notification systems, using lessons learned from COVID-19

 

Host: Dr David Lim | Total Time: 27 mins

Guest:Prof Adrian Esterman, Epidemiologist and Biostatistician

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEST

Click here to register for the next one

<ul>
<li>H5N1 is a highly pathogenic avian flu affecting birds globally, with a higher mortality rate than COVID-19 but limited human-to-human spread</li>
<li>Australia is the only continent without H5N1 cases, with strong pandemic preparedness, including antivirals and vaccine stockpiles</li>
<li>At-risk groups include poultry workers and dairy farmers; exposed individuals should be tested, treated with antivirals, and reported to authorities</li>
<li>Symptoms include respiratory and early GI issues; conjunctivitis has been common in U.S. dairy workers</li>
<li>Australia&rsquo;s new CDC has improved outbreak notification systems, using lessons learned from COVID-19</li>
</ul>
&nbsp;
Host: Dr David Lim | Total Time: 27 mins
Guest: Prof Adrian Esterman, Epidemiologist and Biostatistician
Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEST
<a href="https://www.healthed.com.au/webcast/">Click here to register for the next one</a>

H5N1 avian influenza: Global threats, local preparedness and key risk groups

Natural history of Long COVID, although up to 95% patients will improve their symptoms; it is a long process
Role of vaccination in prevention of Long COVID in patients at higher risk
Role of Metformin in prevention of symptoms of Long COVID and how it is best used in clinics
Type of rehabilitation patients with Long COVID need
Impact on interpersonal relationships and the role of family and community
General practitioners and allied health can together make a significant improvement to patient outcomes

 

Host: Dr David Lim | Total Time: 41 mins

Guest:Prof Steven Faux AM, Rehabilitation and Pain Physician

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

<ul>
<li>Natural history of Long COVID, although up to 95% patients will improve their symptoms; it is a long process</li>
<li>Role of vaccination in prevention of Long COVID in patients at higher risk</li>
<li>Role of Metformin in prevention of symptoms of Long COVID and how it is best used in clinics</li>
<li>Type of rehabilitation patients with Long COVID need</li>
<li>Impact on interpersonal relationships and the role of family and community</li>
<li>General practitioners and allied health can together make a significant improvement to patient outcomes</li>
</ul>
&nbsp;
Host: Dr David Lim | Total Time: 41 mins
Guest: Prof Steven Faux AM, Rehabilitation and Pain Physician
Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEDT
<a href="https://www.healthed.com.au/webcast/">Click here to register for the next one</a>

Long COVID Part 2 – Treatment

Episode 211
Entering a new wave driven by a soup of Omicron sub variants, where more than 5 million Australians eligible for boosters have not received them
How we must encourage patients to get their boosters, with the bivalent vaccines being more effective
Cases of long COVID in Australia ranging between 300K and 1 million, and increasing re-infections escalating the risks
How our health care system had not been designed to cope with long COVID
Continued mask wearing still being very important, and how we must teach our patients about the importance of ventilation, filtration, and air quality
Why the five-day isolation period should be re-introduced


Host: David Lim | Total Time: 30 mins

Guest: Prof Michael Toole AM, Infectious Disease Expert

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

Episode 211
<ul>
<li>Entering a new wave driven by a soup of Omicron sub variants, where more than 5 million Australians eligible for boosters have not received them</li>
<li>How we must encourage patients to get their boosters, with the bivalent vaccines being more effective</li>
<li>Cases of long COVID in Australia ranging between 300K and 1 million, and increasing re-infections escalating the risks</li>
<li>How our health care system had not been designed to cope with long COVID</li>
<li>Continued mask wearing still being very important, and how we must teach our patients about the importance of ventilation, filtration, and air quality</li>
<li>Why the five-day isolation period should be re-introduced</li>
</ul>
 Host: David Lim | Total Time: 30 mins
Guest: Prof Michael Toole AM, Infectious Disease Expert
Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEDT
<a href="https://www.healthed.com.au/webcast/">Click here to register for the next one</a>

Cardiovascular benefits of GLP1s – New evidence

Healthed Australia

Social links

Recent clips